BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15821122)

  • 1. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review.
    Hoei-Hansen CE; Rajpert-De Meyts E; Daugaard G; Skakkebaek NE
    Ann Oncol; 2005 Jun; 16(6):863-8. PubMed ID: 15821122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphology of testicular parenchyma adjacent to germ cell tumours. An interim report.
    Oosterhuis JW; Kersemaekers AM; Jacobsen GK; Timmer A; Steyerberg EW; Molier M; Van Weeren PC; Stoop H; Looijenga LH
    APMIS; 2003 Jan; 111(1):32-40; discussion 41-2. PubMed ID: 12752231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological significance of carcinoma in situ of the testis.
    Jørgensen N; Müller J; Giwercman A; Skakkebaek NE
    Cancer Surv; 1990; 9(2):287-302. PubMed ID: 1964624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumors in subfertile men.
    de Gouveia Brazao CA; Pierik FH; Oosterhuis JW; Dohle GR; Looijenga LH; Weber RF
    J Urol; 2004 Jan; 171(1):158-60. PubMed ID: 14665866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and clinical aspects of carcinoma in situ of the testis.
    Giwercman A; von der Maase H; Skakkebaek NE
    Eur Urol; 1993; 23(1):104-10; discussion 111-4. PubMed ID: 8477770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
    Rajpert-De Meyts E
    Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of the G1/S-phase control in human testicular germ cell tumours.
    Bartkova J; Rajpert-De Meyts E; Skakkebaek NE; Lukas J; Bartek J
    APMIS; 2003 Jan; 111(1):252-65; discussion 265-6. PubMed ID: 12760379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and management of carcinoma in situ of the testis].
    Valentí Moreno V; Tabernero Caturla J; Villavicencio Mavrich H; Paz-Ares L; Santomé Couto L
    Arch Esp Urol; 2000; 53(6):443-6. PubMed ID: 11002510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should the other testis be biopsied?
    Daugaard G; Giwercman A; Skakkebaek NE
    Semin Urol Oncol; 1996 Feb; 14(1):8-12. PubMed ID: 8833382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy.
    Fosså SD; Aass N; Heilo A; Daugaard G; E Skakkebaek N; Stenwig AE; Nesland JM; Looijenga LH; Oosterhuis JW
    Ann Oncol; 2003 Sep; 14(9):1412-8. PubMed ID: 12954581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular microlithiasis and carcinoma in situ overview and proposed clinical guideline.
    van Casteren NJ; Looijenga LH; Dohle GR
    Int J Androl; 2009 Aug; 32(4):279-87. PubMed ID: 19207616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
    Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma in situ of the testis: review of biological and clinical features.
    Dieckmann KP; Skakkebaek NE
    Int J Cancer; 1999 Dec; 83(6):815-22. PubMed ID: 10597201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paternity in patients with bilateral testicular germ cell tumors.
    Heidenreich A; Vorreuther R; Neubauer S; Zumbe J; Engelmann UH
    Eur Urol; 1997; 31(2):246-8. PubMed ID: 9076475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: the recent German experience.
    Dieckmann KP; Loy V
    APMIS; 1998 Jan; 106(1):13-20; discussion 20-3. PubMed ID: 9524558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of carcinoma-in-situ of the testis.
    von der Maase H; Giwercman A; Müller J; Skakkebaek NE
    Int J Androl; 1987 Feb; 10(1):209-20. PubMed ID: 2438219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis.
    Elzinga-Tinke JE; Dohle GR; Looijenga LH
    Asian J Androl; 2015; 17(3):381-93. PubMed ID: 25791729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
    Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
    Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis.
    Oosterhuis JW; Looijenga LH
    APMIS; 2003 Jan; 111(1):280-9. PubMed ID: 12752274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.